At a glance
- Originator Yamanouchi
- Class Antivirals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 24 Jun 2001 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 16 Jul 1998 New profile
- 16 Jul 1998 Preclinical development for HIV infections treatment in Japan (Unknown route)